Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer

Por Zeng, C, Vangveravong, S, McDunn, J E, Hawkins, W G, Mach, R H
Publicado em 2013

Sigma-2 receptors as a biomarker of proliferation in solid tumours

Por Wheeler, K T, Wang, L-M, Wallen, C A, Childers, S R, Cline, J M, Keng, P C, Mach, R H
Publicado em 2000

Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells

Por Al-Nabulsi, I, Mach, R H, Wang, L-M, Wallen, C A, Keng, P C, Sten, K, Childers, S R, Wheeler, K T
Publicado em 1999

Sigma-2 ligands induce tumour cell death by multiple signalling pathways

Por Zeng, C, Rothfuss, J, Zhang, J, Chu, W, Vangveravong, S, Tu, Z, Pan, F, Chang, K C, Hotchkiss, R, Mach, R H
Publicado em 2012

Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats

Por Cheung, T. H. C., Nolan, B. C., Hammerslag, L. R., Weber, S. M., Durbin, J. P., Peartree, N. A., Mach, R. H., Luedtke, R. R., Neisewander, J. L.
Publicado em 2012